Your partner for preclinical studies in oncology
Antineo is a Contract Research Organisation (CRO) that offers preclinical services and expertise in Oncology to accelerate the research programs of private companies and academic institutions.
A custom-made offer corresponding to your needs
Latest news
Testimonials
CasInvent – Pharmaceutical company
“Antineo provided a great service starting with the expert advice on the study design. Their characterized resistance models enabled us to realize a superb efficacy of our lead compound in their in vivo model for pancreatic cancer. Antineo is a trusted partner for our preclinical development.”
Alexander Scheer
Yomi Pharma – Pharmaceutical company
« We worked with Antineo right from the maturation phase of our project, and continued to do so after the company was created. Our studies have always been carried out with competence, rigor, relevance, responsiveness and availability. There’s no doubt that we’ll be calling on them again in the course of our development to cover our preclinical needs. »
Camille Granet
Evextabio – Pharmaceutical company
« We have really benefited from Antineo expertise in preclinical services which has allowed us to establish proof of concept in xenograft models that they have identified, in-licensed and developed for us. Project management is very professionally done with regular reporting in a proactive mode. It is really nice to work with the whole team ! »
Cécile Bougeret
